These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 5651868)

  • 21. The prevalence of rubella haemagglutination inhibition antibodies in non-immunized individuals.
    Tswana SA; Mbengeranwa OL
    Cent Afr J Med; 1984 Jul; 30(7):117-20. PubMed ID: 6488296
    [No Abstract]   [Full Text] [Related]  

  • 22. [Acute rubella virus infection in women of reproductive age in Vojvodina 1994-1995].
    Milosevic V; Jerant-Patić V; Mrda i E; Hrnjaković-Cvjetković I
    Med Pregl; 1997; 50(3-4):81-5. PubMed ID: 9229689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rubella serology in pregnant women attending health centres of Tehran University of Medical Sciences.
    Majlessi F; Batebi A; Shariat M; Rahimi A; Azad TM
    East Mediterr Health J; 2008; 14(3):590-4. PubMed ID: 18720623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rubella immunity levels in the United States population: has the threshold of viral elimination been reached?
    Hyde TB; Kruszon-Moran D; McQuillan GM; Cossen C; Forghani B; Reef SE
    Clin Infect Dis; 2006 Nov; 43 Suppl 3():S146-50. PubMed ID: 16998774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rubella in Umbria (Italy): serological assessment of immunity in adult women and congenital rubella detection after 1978.
    Iorio AM; Greco M; Trabalza N; Cappuccini B; Barboni G; Perocchi F
    Boll Ist Sieroter Milan; 1981; 60(4):278-83. PubMed ID: 7326102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevalence of anti-rubella antibodies in women of childbearing age in Poland.
    Wysokiñska T; Janaszek W; Bucholc B; Gorska P; Gniadek G; Slusarczyk J; Rawicz M
    Vaccine; 2004 May; 22(15-16):1899-902. PubMed ID: 15121301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rubella antibody titres and immunization status in a family practice.
    Mills DA; Parker KR; Evans CE
    Can Med Assoc J; 1980 Mar; 122(5):549-52. PubMed ID: 7370858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a rubella vaccination strategy: contribution of a rubella susceptibility study of women of childbearing age in Kyrgyzstan, 2001.
    Malakmadze N; Zimmerman LA; Uzicanin A; Shteinke L; Caceres VM; Kasymbekova K; Sozina I; Glasser JW; Joldubaeva M; Aidyralieva C; Icenogle JP; Strebel PM; Reef SE
    Clin Infect Dis; 2004 Jun; 38(12):1780-3. PubMed ID: 15227627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of epidemiological peculiarities of rubella based on a mathematical model (according to observations over 10 years in Moscow).
    Kantorovich RA; Gol'dfarb LG; Volodina NI; Myskin AA
    J Hyg Epidemiol Microbiol Immunol; 1983; 27(1):43-50. PubMed ID: 6854012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative sero-epidemiologic observations of rubella infection in pregnant women and female university students.
    Paul MO; Paul BD
    J Hyg Epidemiol Microbiol Immunol; 1983; 27(2):179-83. PubMed ID: 6886415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rubella screening programme--preliminary results in Northern Ireland.
    McClelland WM; McCusker S
    Ulster Med J; 1983; 52(1):67-70. PubMed ID: 6681086
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy of measles and rubella vaccination one year after the nationwide campaign in Shiraz, Iran.
    Pourabbas B; Ziyaeyan M; Alborzi A; Mardaneh J
    Int J Infect Dis; 2008 Jan; 12(1):43-6. PubMed ID: 17950020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serology testing as a means of encouraging rubella immunisation.
    Brieseman MA; Milner AD
    N Z Med J; 1983 Oct; 96(741):760-2. PubMed ID: 6578440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of rubella antibodies among schoolgirls in Sana'a, Republic of Yemen.
    Sallam TA; Raja'a YA; Benbrake MS; Al-Shaibani KS; Al-Hababi AA
    East Mediterr Health J; 2003; 9(1-2):148-51. PubMed ID: 15562744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of immunity against rubella in Iranian after mass campaign for measles-rubella vaccination on December 2003.
    Hamkar R; Jalilvand S; Mokhtari-Azad T; Jelyani KN; Nategh R
    Am J Infect Control; 2006 Nov; 34(9):588-92. PubMed ID: 17097454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Behavior of hemagglutination-inhibiting and neutralizing antibodies in young patients with rubella].
    Grasso A; Scalise G; Gagnoni G; Lunghetti R
    Atti Accad Fisiocrit Siena Med Fis; 1968; 17(2):1109-17. PubMed ID: 5760320
    [No Abstract]   [Full Text] [Related]  

  • 37. Factors associated with low immunity to rubella infection on antenatal screening.
    Sathanandan D; Gupta L; Liu B; Rutherford A; Lane J
    Aust N Z J Obstet Gynaecol; 2005 Oct; 45(5):435-8. PubMed ID: 16171483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Incidence of rubella antibodies and the results of vaccination against rubella in young women].
    Kopeć J; Zgórniak-Nowosielska I
    Przegl Epidemiol; 1994; 48(4):475-9. PubMed ID: 7597186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rubella on a university campus: an evaluation of case immunity histories.
    Strassburg MA; Marquard JL; Fannin SL; Greenland S
    Nurs Res; 1980; 29(6):390-1. PubMed ID: 6903920
    [No Abstract]   [Full Text] [Related]  

  • 40. Re: seroepidemiology study of rubella antibodies among pregnant women from seven Asian countries: evaluation of the rubella vaccination program in Taiwan.
    Arya SC; Agarwal N
    Vaccine; 2006 Nov; 24(49-50):7023. PubMed ID: 16949183
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.